Why Cervical Screening Results Can Feel Confusing
Receiving a cervical screening result — especially one marked "abnormal" — can feel unsettling, even when the finding is minor. The terminology used in these reports is clinical and abbreviated, and letters from labs or providers often don't come with much explanation. Understanding what the language actually means, and what it doesn't mean, is one of the most useful steps a woman can take for her reproductive health.
Cervical screening typically involves a Pap smear (a sample of cells from the cervix examined under a microscope), an HPV test (checking for the presence of high-risk strains of human papillomavirus, the virus that causes most cervical cancers), or both. The combination of these two results shapes the recommended follow-up pathway. For broader context on how screening differs from diagnostic testing, see our overview of screening vs. diagnostic testing.
Abnormal Results Are Common — Not Automatic Cancer
It is important to know that abnormal cervical screening results are relatively common and the vast majority do not lead to a cancer diagnosis. Many low-grade cell changes resolve on their own. However, this does not mean abnormal results should be ignored — timely follow-up is essential. If you feel anxious after receiving a result, speak honestly with your provider about your concerns; they can help put your specific finding in context.
Cervical screening is also one part of a larger picture of preventive care for women over 50. For a comprehensive view of recommended screenings across different health areas, our plain-language overview of cancer screenings for adults over 50 is a helpful companion resource.
Before You Begin: What You'll Need
Having the right materials in hand before you review your results — and before you call your provider — makes the entire process smoother and less stressful.
What you will need
Cervical screening results letter or lab report
Provides the specific result language your provider and this guide will reference.
Patient portal or health record app
Allows you to view full lab details, message your provider, and track follow-up scheduling.
Notebook or notes app
Useful for writing down questions before your follow-up appointment so nothing is forgotten.
Step-by-Step: Reading and Responding to Your Results
Follow these steps in order. Each one builds on the last, moving you from understanding the language on your report through to scheduling and attending appropriate follow-up care.
Read your result category carefully
Cervical screening reports typically use standardized terminology. Common Pap smear result categories include Normal (Negative for Intraepithelial Lesion or Malignancy), ASC-US (atypical squamous cells of undetermined significance), LSIL (low-grade squamous intraepithelial lesion), HSIL (high-grade squamous intraepithelial lesion), and less commonly, ASC-H or findings suggestive of glandular cell changes. Identify exactly which category appears on your report before drawing any conclusions.
Note whether an HPV co-test result is included
Many screening protocols now combine a Pap smear with an HPV co-test — a check for high-risk strains of human papillomavirus. Your follow-up pathway will differ depending on whether your HPV result is positive or negative, even when the Pap result is abnormal. For example, an ASC-US result paired with a negative HPV test generally calls for a different management approach than the same Pap result with a positive HPV test. Locate both results on your report and note them together.
Understand what each common result typically means
Normal / Negative: No abnormal cells were detected. Routine rescreening is recommended on your provider's suggested schedule.
ASC-US with negative HPV: Mildly atypical cells with no high-risk HPV detected. Providers often recommend returning to routine screening rather than immediate further testing.
ASC-US with positive HPV or LSIL: Low-grade changes are present. Guidelines generally recommend closer monitoring — often a repeat co-test in one year or colposcopy, depending on age and history.
HSIL or ASC-H: Higher-grade cell changes. These results typically prompt a referral for colposcopy (a closer examination of the cervix) and possible biopsy. Higher-grade findings require prompt follow-up, but they are still not a diagnosis of cancer.
Contact your provider to confirm next steps
Call or message your gynecologist or primary care provider to discuss your specific result. Ask them to explain the recommended follow-up — whether that means a repeat Pap smear, repeat co-test, colposcopy, or simply returning to your routine schedule. Bring or reference your written results so the conversation is grounded in the precise language on your report. It is also a good moment to raise questions about your personal risk factors, such as your vaccination history and smoking status, both of which can affect cervical cell health.
Schedule and attend the recommended follow-up
Once your provider recommends a specific follow-up action — whether that is a colposcopy referral, a repeat test in six to twelve months, or a return to annual or three-year screening — schedule it before leaving the office or ending the call. Mark the date in your calendar. If a colposcopy is recommended, ask what to expect during the procedure so you feel prepared. Colposcopy is an outpatient examination that typically takes about fifteen to twenty minutes and involves looking closely at the cervix with a lighted magnifying instrument.
Keep a personal record of your screening history
Maintain a simple log of each screening date, the result category, and the follow-up action taken. This is especially useful if you change providers, move, or have a gap in care. Your provider also keeps records, but having your own summary ensures continuity. Note the date of your next recommended screening so you can proactively schedule it rather than waiting for a reminder.
Screening Frequency Varies by Age and History
Current U.S. guidelines generally recommend Pap smears every three years for women aged 21–65, or a Pap plus HPV co-test every five years for women aged 30–65 who have had consistently normal results. Women over 65 with a history of adequate normal screening may be advised they no longer need routine screening. Your provider will tailor these intervals based on your personal history, so always confirm your individual schedule rather than assuming a one-size-fits-all approach.
After Your Follow-Up: Staying on Track
Cervical health is managed over time, not through a single appointment. Once your immediate follow-up is complete, work with your provider to confirm your next recommended screening date and ask whether any lifestyle factors — such as smoking cessation support — are worth addressing. HPV vaccination history is also relevant; if you have questions about your vaccination status, raise them with your provider.
Seek Care Promptly for High-Grade Results
If your result indicates HSIL, ASC-H, or any glandular cell abnormality, contact your provider promptly — ideally within a few days of receiving the result. These categories warrant timely evaluation, typically including colposcopy. Delaying follow-up on high-grade findings increases the risk of missing a developing condition at an earlier, more manageable stage. This guidance is especially important for women who have had gaps in screening.
Managing cervical screening results shares some important principles with other preventive screenings — including understanding what a result does and doesn't mean, and knowing which questions to raise with your care team. If you're also preparing for a cardiovascular checkup, our guide to reading a heart health checkup offers a similar framework for navigating those conversations confidently.
This article is for general informational and educational purposes only and does not constitute medical advice. Cervical screening guidelines and follow-up protocols are individualized — always consult a qualified healthcare provider to understand your specific results and appropriate next steps.
